🇺🇸 FDA
Patent

US 11491133

Heteroaryl-isochroman compounds and uses thereof

granted A61KA61K31/352A61K31/4155

Quick answer

US patent 11491133 (Heteroaryl-isochroman compounds and uses thereof) held by PGI Drug Discovery LLC expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PGI Drug Discovery LLC
Grant date
Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
57
CPC classes
A61K, A61K31/352, A61K31/4155, A61K31/4178, A61K31/42